Migdal Insurance & Financial Holdings’s Biogen BIIB Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13	Closed	-$3K	–	744
2019 Q2	$3K	Hold	13	–	–	﹤0.01%	726
2019 Q1	$3K	Hold	13	–	–	﹤0.01%	689
2018 Q4	$4K	Hold	13	–	–	﹤0.01%	686
2018 Q3	$5K	Sell	13 -615	-98%	-$212K	﹤0.01%	765
2018 Q2	$182K	Buy	628 +596	+1,863%	+$168K	﹤0.01%	448
2018 Q1	$9K	Sell	32 -296	-90%	-$91.9K	﹤0.01%	557
2017 Q4	$104K	Hold	328	–	–	﹤0.01%	372
2017 Q3	$103K	Hold	328	–	–	﹤0.01%	363
2017 Q2	$90K	Hold	328	–	–	﹤0.01%	357
2017 Q1	$88K	Buy	328 +269	+456%	+$76.1K	﹤0.01%	366
2016 Q4	$17K	Buy	+59	New	+$17.5K	﹤0.01%	374

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Migdal Insurance & Financial Holdings's BIIB Position: Q3 2019 in Review

Migdal Insurance & Financial Holdings sold out of Biogen (BIIB) in Q3 2019, closing a stake of 13 shares — an estimated $3K sold.

Migdal Insurance & Financial Holdings first reported a position in BIIB in Q4 2016 and held it in 11 quarters. The position peaked at $182K in Q2 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Migdal Insurance & Financial Holdings reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 13 Biogen shares in Q3 2019, an estimated $3K.
Migdal Insurance & Financial Holdings first reported a position in Biogen in Q4 2016 and held it in 11 quarters.
Migdal Insurance & Financial Holdings's Biogen position peaked at $182K in Q2 2018.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2019, filed 12 Nov 2019.